Specialty Pharmacy

Patients with psychological and substance use problems are less likely to stay engaged in hepatitis C care.

Texas-based pharmacies work to ensure access to lifesaving medications for patients displaced and homeless due to the flooding caused by Hurricane Harvey.

High-dose vitamin C found to revert leukemia stem cells with a specific mutation back to normal cells.

Communicating with a psychologist via email improved stress and depression symptoms among parents of children with cancer.

The findings highlight the role of Tregs in suppressing the immune response.

Targeting the arginase 2 enzyme observed to reduce the growth of pancreatic cancer.

Top news of the day from across the healthcare landscape.

Patients who were adherent to oral diabetes drugs spent $500 less on health care compared with nonadherent patients.

Tisagenlecleucel is indicated for pediatric and young adult patients with B-cell precursor acute lymphoblastic leukemia.

Approximately 12,000 customers were affected by the breach.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, talks about the importance of care coordination.

Scientists hone in on personalized treatments for patients with cancer.

Top news of the day from across the health care landscape.

An estimated 1.2 million American women would likely benefit from recommended genetic test to assess their risk of cancer.

The risk of developing liver cancer is similar with direct-acting antiviral drugs or interferon therapy for hepatitis C virus.

Attendees of the National Association of Specialty Pharmacy annual meeting have the chance to see the nation’s capital during downtime.

Cyltezo approved for the same indications as Humira, including rheumatoid arthritis, psoriatic arthritis, and Crohn’s disease.

The $2 million grant seeks to help establish guidelines for further development of treatments for HIV.

Alcohol consumption results in more than $150 million spent on breast cancer annually.

Top news of the day from across the healthcare landscape.

Experimental drug shows evidence of lowering cholesterol, reducing risk of cardiovascular disease, and potentially treating lung cancer.

Faslodex reduced disease progression by 20% among women with HR+, HER2- advanced breast cancer.

A decision on the approval of obinutuzumab is expected by December 23, 2017.

Use of oral contraceptives for 7 or more consecutive years associated with lower risk of rheumatoid arthritis.

Top news of the day from across the health care landscape.

Findings may lead to new targeted treatment options for HIV infection.

Prophylactic mastectomy for ovarian cancer survivors with BRCA mutations may not improve survival.

Hormone therapy is recommended to treat menopause symptoms, but is not recommended for breast cancer survivors.